Stock Rich List
#4740 on the rich list of 14,644 insiders

Gary A. Lyons

Director at Neurocrine Biosciences; Director at Travere Therapeutics; Director at Rigel Pharmaceuticals. Based in San Diego, California.

$22.6M
in disclosed stock, −$718K (−3.08%) today
Live prices, last trade 3:17 PM ET
Rank
4740th of 14,644
Companies held
3
Largest holding
NBIX, 85.6% of total
Latest SEC filing
Aug 18, 2026

What the $22.6M is made of

Holdings counted

All filings on SEC.gov
CompanyHow heldSharesPriceValueShare of totalReported
Neurocrine Biosciences NBIX
Common Stock
Directly122,141$158.18$19.3M85.6%Form 4, May 21, 2026
Travere Therapeutics TVTX
Common Stock
Directly61,500$48.00$3.0M13.1%Form 4, Aug 18, 2026
Rigel Pharmaceuticals RIGL
Common Stock
Directly7,500
split-adjusted
$41.39$310K1.4%Form 4, May 26, 2023

Share counts are the amounts Gary A. Lyons reported owning after each line of their latest filing for that company, adjusted for any later stock splits. Values use the latest price. Methodology.

Open-market trades, last 12 months

DateTradeCompanySharesPriceValueFiling
Aug 18, 2026SoldTVTX900$63.86$57KView
Aug 18, 2026SoldTVTX4,100$63.27$259KView
Aug 17, 2026SoldTVTX1,900$62.53$119KView
Aug 17, 2026SoldTVTX2,600$63.50$165KView
Aug 17, 2026SoldTVTX500$64.16$32KView
Apr 14, 2026SoldTVTX8,000$41.07$329KView
Dec 3, 2025SoldNBIX15,000$152.61$2.3MView

Nearby on the list

Full list
Nearby ranks
RankNameStock holdingsToday
4737Sara Yang Bosco
Sr VP, Secy & Chf Leg Ofc, Emerson Electric. St. Louis, MO
$22.6M−$562K (−2.43%)
4738Michael Tabor
10% owner, iHeartMedia
$22.6M−$3.2M (−12.55%)
4739Gene H. Wickes
Head of Benefits Deliv & Admin, Willis Towers Watson Public Limited
$22.6M−$101K (−0.45%)
4740Gary A. Lyons
Director, Neurocrine Biosciences. San Diego, CA
$22.6M−$718K (−3.08%)
4741Nancy Quan
Executive Vice President, The Coca-Cola. Atlanta, GA
$22.6M−$472K (−2.05%)
4742Ross Tennenbaum
Chief Financial Officer, Dropbox. San Francisco, CA
$22.6M−$657K (−2.83%)
4743Gary A. Norcross
Chairman and CEO, Fidelity National Information Services. Jacksonville, FL
$22.6M−$873K (−3.72%)

Other Neurocrine Biosciences insiders

All NBIX insiders

Questions

How much stock does Gary A. Lyons own?

Gary A. Lyons holds $22,582,688 in listed stock based on SEC filings and current prices, mostly Neurocrine Biosciences (NBIX). That ranks 4740th on the Stock Rich List.

Is this Gary A. Lyons's net worth?

No. It counts only listed shares reported on SEC Forms 3, 4 and 5. Cash, private companies, real estate, options and holdings that don't need to be reported are not included, so total net worth is likely different.

When did Gary A. Lyons last buy or sell stock?

The most recent open-market trade on file is a sale of 900 TVTX shares on Aug 18, 2026 at $63.86.